Report cover image

Oligonucleotides: Global Markets

Publisher BCC Research
Published Jan 21, 2026
Length 125 Pages
SKU # WA20791198

Description

Report Scope

The report provides an overview of the oligonucleotides market and analyzes market trends. It includes global revenue ($ Million) for the base year 2024, estimated data for 2025 and forecast data from 2026 through 2030. The market is segmented by product type, application and region.

By product type, the market is segmented into oligonucleotide drugs, synthesized oligos, equipment and reagents, and services. The application segment is characterized by research and therapeutics and diagnostics. The report also includes an overview of the regulatory landscape for oligonucleotides.

The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, the Asia-Pacific and the rest of the world (RoW), with a focus on major countries in these regions.

The report focuses on the major driving trends and challenges affecting the market and vendor landscape. It analyzes environmental, social and governance (ESG) developments and discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape and industry structure. It also includes a dedicated section of company profiles, detailing leading market companies.

Report Includes
  • 64 data tables and 55 additional tables
  • In-depth analysis of the global oligonucleotides market
  • Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
  • Estimates of the current market size and revenue prospects for the global oligonucleotide synthesis market, accompanied by a market share analysis by product, application and region
  • Facts and figures pertaining to the global market dynamics, opportunities and deterrents, technological advancements, regulations, prospects and the impact of macroeconomic factors
  • Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
  • Patent review, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Company profiles of major players within the industry, including Alnylam Pharmaceuticals Inc., Biogen/Ionis Pharmaceuticals Inc., Novartis AG, and Sarepta Therapeutics Inc.


Companies Mentioned

Bitzer
Blue Star Ltd.
Daikin Industries Ltd.
Danfoss A/S
Dover Corp.
Gea Group Aktiengesellschaft
Hussmann Corp.
Illinois Tool Works Inc.
Imbera
Johnson Controls
Sis Refrigeration
True Manufacturing Co. Inc.
Uab Freor Lt
Western Refrigeration Pvt. Ltd.
Williams Refrigeration"




"Agilent Technologies Inc.
Ajinomoto Bio-pharma
Alnylam Pharmaceuticals Inc.
Astellas Pharma Inc.
Biogen
Charles River Laboratories
Eurofins Genomics
Genscript
Integrated Dna Technologies Inc.
Merck Kgaa
Novartis Ag
Novo Nordisk A/S
Revvity
Sarepta Therapeutics Inc.
Thermo Fisher Scientific Inc.

Table of Contents

125 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Types of Oligonucleotides
Mechanisms of Action of Oligonucleotides
Oligonucleotide Synthesis Processes
Solid Phase Chemical Synthesis
Porter’s Five Forces Analysis in the Global Oligonucleotides Market
Macroeconomic Factor Analysis
Impact of the U.S. Tariffs
Growing Rare Disease Funding
Geopolitical Factors
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Focus on Personalized Medicine
Increasing Use of Synthesized Oligos in Therapeutic Applications
Rising Prevalence of Rare Diseases
Market Restraints/Challenges
Product Withdrawals and Clinical Trial Failures
Complexities Associated with Oligos Manufacturing
High Treatment Costs of Oligonucleotide Therapeutics
Market Opportunities
Expanding Application Areas of Oligonucleotides
Expansion of Companies
DNA Nanotechnology for Drug Delivery
Chapter 4 Regulatory Landscape
Regulatory Paths for Oligonucleotide Therapeutics
U.S.
European Union
Asia-Pacific
Chapter 5 Emerging Technologies
Key Takeaways
Emerging Technologies
Enzymatic Oligonucleotide Synthesis
Advances in RNAi Delivery Systems
Circulating miRNA Diagnostics for Noninvasive Health Monitoring
Innovative Oligonucleotide Conjugation Methods
Pipeline Analysis
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Oligonucleotide Drugs
Synthesized Oligos
Equipment and Reagents
Services
Market Analysis by Application
Key Takeaways
Diagnostics and Therapeutics
Research
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Industry Structure
Company Share Analysis of the Global Oligonucleotides Market
Strategic Analysis
Funding Outlook
Chapter 8 Sustainability in the Global Oligonucleotides Market: An ESG Perspective
Introduction to ESG
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
AJINOMOTO BIO-PHARMA
ALNYLAM PHARMACEUTICALS INC.
ASTELLAS PHARMA INC.
BIOGEN
CHARLES RIVER LABORATORIES
EUROFINS GENOMICS
GENSCRIPT
INTEGRATED DNA TECHNOLOGIES INC.
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
REVVITY
SAREPTA THERAPEUTICS INC.
THERMO FISHER SCIENTIFIC INC.
Emerging Startups/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us